COL3A1 Genes Variations Analysis
COL3A1 gene encodes component of type III collagen called, proα1(III) chain, that is found in the skin, lungs, intestinal walls, and the walls of blood vessels. COL3A1 is located on the long (q) arm of chromosome 2 at position 32.2. Mutations in this gene are associated with Vascular Ehlers-Danlos syndrome types IV.
Vascular Ehlers-Danlos syndrome is an autosomal dominant disorder containing COL3A1 pathogenic variants in 90-95% of cases. The COL3A1 mutation may be either inherited from an affected parent or be de novo. In Ehlers-Danlos syndrome types IV, COL3A1 gene mutations alter the structure of type III collagen that leads to intracellular storage and impaired secretion of collagen chains. Therefore, this disorder affects the connective tissues that support the skin, bones, blood vessels, and many other organs and tissues and clinically may cause life-threatening arterial rupture and increased risk of organ rupture, including tearing of the intestine and rupture of the uterus during pregnancy. The syndrome has an estimated prevalence of 1/150 000. Other features include translucent skin with highly visible subcutaneous vessels on the trunk and lower back, and easy bruising.
More than 570 COL3A1 genetic variants have been registered in the Ehlers–Danlos syndrome variant database. The most common mutation identified result in substitution of other amino acids for glycine residues in the Gly-X-Y triplets of the triple helical domain.
- As aid in diagnosis of Marfan Syndrome
- Aid in the diagnosis of Ehlers–Danlos Syndrome type IV
- To identify the carrier of pathogenic variants of COL3A1
- Identification of pathogenic variant in COL3A1 helps for prenatal testing for pregnancies at increased risk and preimplantation genetic diagnosis
Negative:
- No COL3A1 pathogenic variants found indicates no disease.
Positive:
- Presence of COL3A1 pathogenic variants such as small intragenic deletions/insertions and missense, nonsense and splice site variants is consistent with the disease.
Whole blood (Levander top tube).
Stability
- Ambient: 72 hours
- Refrigerated: 1 week
- Frozen: Unacceptable
- Gene. 2019;707:151-171. Review. [PMID: 31075413]
- J Med Case Rep. 2016;10:303. [PMID: 27799058]
- Mol Med Rep. 2015;12:1119-1124. [PMID: 25776230]
- Eur J Hum Genet. 2015;23:1657-1664. [PMID: 25758994]
- Curr Opin Cardiol. 1998 May;13(3):198-204. [PMID: 9649943]
- Acta Med Port. 2011;24:1079-1086. [PMID: 22713205]
- J Nippon Med Sch. 2008;75:254-61. Review. [PMID: 19023163]
- J Invest Dermatol. 1997;108:241-247. [PMID: 9036918]